Stay updated with breaking news from Summit Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Summit Therapeutics Inc. (NASDAQ:SMMT – Get Free Report)’s share price traded up 8.1% during mid-day trading on Wednesday . The company traded as high as $7.92 and last traded at $7.90. 2,589,140 shares traded hands during mid-day trading, a decline of 19% from the average session volume of 3,208,273 shares. The stock had previously closed […]
Plus: Annie Lamont, Robert Nelsen, Hemant Taneja and more healthtech venture capital investors on this year's Forbes Midas list.
Summit Therapeutics (NASDAQ:SMMT) is a Miami-based biopharmaceutical company that is focused on discovery, development, and the commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the United States and the ...
While commercial uptake may be difficult for ivonescimab, a positive regulatory decision would help validate Akeso's bispecific platform.
Summit Therapeutics Inc. (SMMT.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Summit Therapeutics Inc. | Nasdaq: SMMT | Nasdaq